{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:01:06Z","timestamp":1792389666294,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10147-022-02216-7","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T16:20:37Z","timestamp":1658161237000},"page":"1605-1615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4928-254X","authenticated-orcid":false,"given":"Amir Hossein","family":"Aalami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5018-2581","authenticated-orcid":false,"given":"Farnoosh","family":"Aalami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"issue":"3","key":"2216_CR1","doi-asserted-by":"publisher","first-page":"272e1","DOI":"10.1016\/j.clgc.2020.09.002","volume":"19","author":"B Foerster","year":"2021","unstructured":"Foerster B, Abufaraj M, Mari A et al (2021) The performance of tumor size as risk stratification parameter in upper tract urothelial carcinoma (UTUC). Clin Genitourin Cancer 19(3):272e1-e7","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"2216_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","volume":"79","author":"M Roupr\u00eat","year":"2020","unstructured":"Roupr\u00eat M, Babjuk M, Burger M et al (2020) EAU guidelines on upper urinary tract urothelial carcinoma 2020. Eur Urol 79(1):62\u201379","journal-title":"Eur Urol"},{"issue":"5","key":"2216_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","volume":"79","author":"JJ Leow","year":"2021","unstructured":"Leow JJ, Chong YL, Chang SL et al (2021) Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy. Eur Urol 79(5):635\u2013654","journal-title":"Eur Urol"},{"issue":"3","key":"2216_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","volume":"35","author":"F Soria","year":"2017","unstructured":"Soria F, Shariat SF, Lerner SP et al (2017) Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol 35(3):379\u2013387","journal-title":"World J Urol"},{"issue":"1","key":"2216_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-021-00876-7","volume":"21","author":"A Soualhi","year":"2021","unstructured":"Soualhi A, Rammant E, George G et al (2021) The incidence and prevalence of upper tract urothelial carcinoma: a systematic review. BMC Urol 21(1):1\u201311","journal-title":"BMC Urol"},{"issue":"11","key":"2216_CR6","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/PAS.0000000000001141","volume":"42","author":"JY Ju","year":"2018","unstructured":"Ju JY, Mills AM, Mahadevan MS et al (2018) Universal Lynch syndrome screening should be performed in all upper tract urothelial carcinomas. Am J Surg Pathol 42(11):1549\u20131555","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 2","key":"2216_CR7","doi-asserted-by":"publisher","first-page":"S248","DOI":"10.21037\/tau.2018.05.07","volume":"7","author":"F Sanguedolce","year":"2018","unstructured":"Sanguedolce F, Cormio L (2018) The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues. Transl Androl Urol 7(Suppl 2):S248","journal-title":"Transl Androl Urol"},{"key":"2216_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OTT.S225301","volume":"13","author":"JJ Leow","year":"2020","unstructured":"Leow JJ, Liu Z, Tan TW et al (2020) Optimal management of upper tract urothelial carcinoma: current perspectives. Onco Targets Ther 13:1","journal-title":"Onco Targets Ther"},{"issue":"6","key":"2216_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.urolonc.2022.01.014","volume":"40","author":"J Stangl-Kremser","year":"2022","unstructured":"Stangl-Kremser J, Muto G, Grosso AA et al (2022) The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: an extensive updated systematic review and meta-analysis. Urol Oncol 40(6):243\u2013261","journal-title":"Urol Oncol"},{"key":"2216_CR10","doi-asserted-by":"publisher","first-page":"557309","DOI":"10.1155\/2021\/5557309","volume":"2021","author":"AH Aalami","year":"2021","unstructured":"Aalami AH, Abdeahad H, Mesgari M et al (2021) Urinary angiogenin as a marker for bladder cancer: a meta-analysis. Biomed Res Int 2021:557309","journal-title":"Biomed Res Int"},{"issue":"8","key":"2216_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.humpath.2007.04.015","volume":"38","author":"KC Halling","year":"2007","unstructured":"Halling KC, Kipp BR (2007) Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 38(8):1137\u20131144","journal-title":"Hum Pathol"},{"key":"2216_CR12","doi-asserted-by":"publisher","DOI":"10.1201\/9781315120553","volume-title":"Tumors and cancers: skin-soft tissue\u2013bone\u2013urogenitals","author":"D Liu","year":"2017","unstructured":"Liu D (2017) Tumors and cancers: skin-soft tissue\u2013bone\u2013urogenitals. CRC Press, Boca Raton"},{"issue":"7","key":"2216_CR13","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.molcel.2021.02.011","volume":"81","author":"Y Wang","year":"2021","unstructured":"Wang Y, Cottle WT, Wang H et al (2021) Genome oligopaint via local denaturation fluorescence in situ hybridization. Mol Cell 81(7):1566-1577.e8","journal-title":"Mol Cell"},{"issue":"11","key":"2216_CR14","first-page":"4761","volume":"30","author":"M Maffezzini","year":"2010","unstructured":"Maffezzini M, Campodonico F, Capponi G et al (2010) Prognostic significance of fluorescent in situ hybridisation in the follow-up of non-muscle-invasive bladder cancer. Anticancer Res 30(11):4761\u20134765","journal-title":"Anticancer Res"},{"key":"2216_CR15","volume-title":"Urologic oncology: seminars and original investigations","author":"Y Lotan","year":"2010","unstructured":"Lotan Y, Shariat SF, Schmitz-Dr\u00e4ger BJ et al (2010) Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. In: Barton H (ed) Urologic oncology: seminars and original investigations. Elsevier, Amsterdam"},{"key":"2216_CR16","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.12659\/MSM.910134","volume":"24","author":"T Yang","year":"2018","unstructured":"Yang T, Li Y, Li J et al (2018) Diagnostic value comparison of urothelium carcinoma among urine exfoliated cells fluorescent in situ hybridization (FISH) examination, computerized tomography (CT) scan, and urine cytologic examination. Med Sci Monit: Intern Med J Exp Clin Res 24:5788","journal-title":"Med Sci Monit: Intern Med J Exp Clin Res"},{"issue":"6","key":"2216_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/cncy.20168","volume":"119","author":"AB Galv\u00e1n","year":"2011","unstructured":"Galv\u00e1n AB, Salido M, Espinet B et al (2011) A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non\u2013muscle-invasive urothelial cell carcinoma: a prospective study. Cancer Cytopathol 119(6):395\u2013403","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"2216_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/cncy.20099","volume":"118","author":"NP Caraway","year":"2010","unstructured":"Caraway NP, Khanna A, Fernandez RL et al (2010) Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study. Cancer Cytopathol 118(5):259\u2013268","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"2216_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MD McInnes","year":"2018","unstructured":"McInnes MD, Moher D, Thombs BD et al (2018) Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA 319(4):388\u2013396","journal-title":"JAMA"},{"issue":"14","key":"2216_CR20","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/sim.4780121403","volume":"12","author":"LE Moses","year":"1993","unstructured":"Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12(14):1293\u20131316","journal-title":"Stat Med"},{"key":"2216_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jclinepi.2020.12.015","volume":"132","author":"L Furuya-Kanamori","year":"2021","unstructured":"Furuya-Kanamori L, Kostoulas P, Doi SA (2021) A new method for synthesizing test accuracy data outperformed the bivariate method. J Clin Epidemiol 132:51\u20138","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"2216_CR22","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/dc.23796","volume":"45","author":"X Sun","year":"2017","unstructured":"Sun X, Liu X, Xia M et al (2017) The combined application of urinary liquid-based cytology with fluorescence in situ hybridization and p16\/Ki-67 dual immunostaining is valuable for improving the early diagnosis of upper tract urothelial carcinomas. Diagn Cytopathol 45(10):895\u2013902","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"2216_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cancergencyto.2010.07.133","volume":"203","author":"Z Shan","year":"2010","unstructured":"Shan Z, Wu P, Zheng S et al (2010) Evaluation of upper urinary tract tumors by FISH in Chinese patients. Cancer Genet Cytogenet 203(2):238\u2013246","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"2216_CR24","first-page":"8620","volume":"24","author":"LG Gomella","year":"2017","unstructured":"Gomella LG, Mann MJ, Cleary RC et al (2017) Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date. Can J Urol 24(1):8620\u20138626","journal-title":"Can J Urol"},{"issue":"4","key":"2216_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.urology.2007.06.1103","volume":"70","author":"T Akkad","year":"2007","unstructured":"Akkad T, Brunner A, Pallwein L et al (2007) Fluorescence in situ hybridization for detecting upper urinary tract tumors\u2014a preliminary report. Urology 70(4):753\u2013757","journal-title":"Urology"},{"issue":"6","key":"2216_CR26","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1089\/end.2008.0096","volume":"22","author":"AA Chen","year":"2008","unstructured":"Chen AA, Grasso M (2008) Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma? J Endourol 22(6):1371\u20131374","journal-title":"J Endourol"},{"issue":"1","key":"2216_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3892\/ol.2016.4592","volume":"12","author":"Q Yu","year":"2016","unstructured":"Yu Q, Li Y, Li G et al (2016) Prospective evaluation of FISH for detecting upper tract urothelial carcinoma in voided urine specimens. Oncol Lett 12(1):183\u2013188","journal-title":"Oncol Lett"},{"issue":"5","key":"2216_CR28","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.3892\/ol.2017.5926","volume":"13","author":"T Lin","year":"2017","unstructured":"Lin T, Liu Z, Liu L et al (2017) Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma. Oncol Lett 13(5):3928\u20133934","journal-title":"Oncol Lett"},{"issue":"3","key":"2216_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.urology.2010.07.498","volume":"77","author":"C Xu","year":"2011","unstructured":"Xu C, Zeng Q, Hou J et al (2011) Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients. Urology 77(3):636\u2013641","journal-title":"Urology"},{"issue":"4","key":"2216_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4103\/jcrt.JCRT_74_17","volume":"13","author":"J Yu","year":"2017","unstructured":"Yu J, Xiong H, Wei C et al (2017) Utility of fluorescence in situ hybridization analysis for detecting upper urinary tract-urothelial carcinoma. J Cancer Res Ther 13(4):647","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"2216_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.eururo.2006.08.045","volume":"51","author":"M Mar\u00edn-Aguilera","year":"2007","unstructured":"Mar\u00edn-Aguilera M, Mengual L, Ribal MJ et al (2007) Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol 51(2):409\u2013415","journal-title":"Eur Urol"},{"issue":"2","key":"2216_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cancergencyto.2008.10.015","volume":"189","author":"B Luo","year":"2009","unstructured":"Luo B, Li W, Deng C-H et al (2009) Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. Cancer Genet Cytogenet 189(2):93\u201397","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"2216_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1159\/000341622","volume":"56","author":"J Wang","year":"2012","unstructured":"Wang J, Wu J, Peng L et al (2012) Distinguishing urothelial carcinoma in the upper urinary tract from benign diseases with hematuria using FISH. Acta Cytol 56(5):533\u2013538","journal-title":"Acta Cytol"},{"issue":"4","key":"2216_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4149\/neo_2012_046","volume":"59","author":"W Huang","year":"2012","unstructured":"Huang W, Li L, Pang J et al (2012) Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology. Neoplasma 59(4):355\u2013360","journal-title":"Neoplasma"},{"issue":"4","key":"2216_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1006\/enfo.2001.0061","volume":"2","author":"TD Gauthier","year":"2001","unstructured":"Gauthier TD (2001) Detecting trends using Spearman\u2019s rank correlation coefficient. Environ Forensics 2(4):359\u2013362","journal-title":"Environ Forensics"},{"key":"2216_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:101\u20131088","journal-title":"Biometrics"},{"issue":"7109","key":"2216_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"7","key":"2216_CR38","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.21037\/tau-21-309","volume":"10","author":"W Zhu","year":"2021","unstructured":"Zhu W, Zheng M, Xiong S et al (2021) Modified Takazawa anatomical classification of renal pelvicalyceal system based on three-dimensional virtual reconstruction models. Transl Androl Urol 10(7):2944","journal-title":"Transl Androl Urol"},{"issue":"5","key":"2216_CR39","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00345-019-02875-8","volume":"38","author":"F Janisch","year":"2020","unstructured":"Janisch F, Shariat SF, Baltzer P et al (2020) Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis. World J Urol 38(5):1165\u20131175","journal-title":"World J Urol"},{"issue":"2","key":"2216_CR40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/JU.0000000000001370","volume":"205","author":"A Gallioli","year":"2021","unstructured":"Gallioli A, Territo A, Mercad\u00e9 A et al (2021) The impact of ureteroscopy following computerized tomography urography in the management of upper tract urothelial carcinoma. J Urol 205(2):392\u2013399","journal-title":"J Urol"},{"issue":"6","key":"2216_CR41","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/cancers14061520","volume":"14","author":"\u0141 Bia\u0142ek","year":"2022","unstructured":"Bia\u0142ek \u0141, Bilski K, Dobruch J et al (2022) Non-invasive biomarkers in the diagnosis of upper urinary tract urothelial carcinoma\u2014a systematic review. Cancers 14(6):1520","journal-title":"Cancers"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-022-02216-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02216-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T03:26:01Z","timestamp":1668569161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-022-02216-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1007\/s10147-022-02216-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study described has not involved experimentation on animals or humans.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This publication does not involve volunteers or patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}